Share on StockTwits
 

Genus (LON:GNS)‘s stock had its “sell” rating restated by equities researchers at Panmure Gordon in a research report issued on Wednesday, Analyst Ratings News reports. They currently have a GBX 1,210 ($20.28) price target on the stock. Panmure Gordon’s target price indicates a potential upside of 0.58% from the company’s current price.

Shares of Genus (LON:GNS) traded up 0.25% during mid-day trading on Wednesday, hitting GBX 1203.00. 35,118 shares of the company’s stock traded hands. Genus has a 1-year low of GBX 1178.00 and a 1-year high of GBX 1609.00. The stock has a 50-day moving average of GBX 1319. and a 200-day moving average of GBX 1329.. The company’s market cap is £727.2 million.

Several other analysts have also recently commented on the stock. Analysts at Liberum Capital reiterated a “buy” rating on shares of Genus in a research note on Friday, January 10th. They now have a GBX 1,550 ($25.98) price target on the stock. Separately, analysts at Nplus1 Brewin cut their price target on shares of Genus from GBX 1,357 ($22.74) to GBX 1,255 ($21.03) in a research note on Wednesday, December 4th. They now have a “hold” rating on the stock. Finally, analysts at N+1 Singer cut their price target on shares of Genus from GBX 1,357 ($22.74) to GBX 1,255 ($21.03) in a research note on Wednesday, December 4th. They now have a “hold” rating on the stock. Two analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company. Genus has a consensus rating of “Hold” and an average price target of GBX 1,401.29 ($23.48).

Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.